Kapitall submits: Here we present 5 small cap stocks that have seen net institutional selling over the current and prior quarters. However these stocks have also seen significant insider buying over the same period. Do you think these insiders know something that institutions and the rest of us ...
We're dropping coverage of Hansen Medical HNSN to focus our resources elsewhere.
Hansen Medical HNSN reported second-quarter earnings that came in slightly below our estimates and also suspended management's annual system sales
We're placing Hansen Medical HNSN under review after the firm announced disappointing preliminary first - quarter revenue growth . We expect to lower our projections
Hansen Medical HNSN reported fourth-quarter results Tuesday, and we are likely to hold on to our fair value estimate. Sales came in slightly above
Hansen Medical HNSN reported Friday that it settled a lawsuit with Luna Innovations LUNA regarding a contract breach and trade secrets. The settlement
Hansen Medical HNSN has completed its restatement of financial results and reported disappointing sales figures for the third quarter. We will consider
Hansen Medical HNSN announced Monday that it needs to restate its prior financial results in order to correct some potential errors in its revenue
reins in operating costs. We don't think competitive pressures played a role in its current weakness, as rival Hansen Medical HNSN experienced system sales declines as well. However, it is possible that hospitals could opt to buy Hansen's
Hansen Medical HNSN reported full second-quarter results Tuesday that were in line with our expectations, and we are maintaining our fair value